Results 221 to 230 of about 969,569 (304)

Interlaboratory Evaluation of Multiplex Autoantibody Assay Performance in the Islet Autoantibody Standardization Program 2024 Workshop. [PDF]

Diabetes Care
Marzinotto I, Pittman DL, Achenbach P, Akolkar B, Wasserfall CH, Lampasona V, Long AE.   +6 more
europepmc   +1 more source

Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer

FEBS Open Bio, EarlyView.
ERα splice variant ERα∆7 lacks the C‐terminus, and its expression may change phenotypes of breast cancers. Our results showed that ERα∆7 is found in the luminal A subtype, and elevated ERα∆7 levels are linked to improved cell survival with lower proliferation and migration.
Long Wai Tsui, Taobo Hu, Thomson Christian Husein, Wai Hei Shek, Bingrong Chen, Depeng Wang, Shu Wang, Weichuan Yu, Xiaodan Fan, Mengping Long, Toyotaka Ishibashi   +10 more
wiley   +1 more source

Editorial: Antibody can get it right: confronting problems of antibody specificity and irreproducibility.

Mol Endocrinol, 2014
Schonbrunn A.
europepmc   +1 more source

Development of human monoclonal antibodies against TARM1 by yeast display

FEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe, Mayumi Saeki, Masaaki Hashiguchi, Sayaka Ono, Kazuhisa Aoki, Hidetaka Tanno   +5 more
wiley   +1 more source

Validation of TRPA1 and TRPV1 Antibodies for Expression Detection in Mammalian Cells and Tissues. [PDF]

J Neurochem
de Las Casas M, Hernández-Ortego P, Torres-Montero R, De la Peña E, Gomis A, Viana F, Fernández-Trillo J.   +6 more
europepmc   +1 more source

Enhancement of experimental cutaneous leishmaniasis by Leishmania extract: identification of a disease-associated antibody specificity. [PDF]

BMC Res Notes, 2015
Silva VM, de-Araújo CF, Navarro IC, Oliveira PR, Pontes-de-Carvalho L.   +4 more
europepmc   +1 more source

Screening and epitope characterization of Nidogen‐2‐specific nanobodies

FEBS Open Bio, EarlyView.
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen, Qianqian Cui, Zhongyun Lan, Yingjun Wang, Shuaiying Zhao, Wenxuan Feng, Yunfeng Liu, Qiting Huang, Dongna Zhang, Jianfeng Xu   +9 more
wiley   +1 more source

A Next-Generation ELISA for the Detection of Anti-(Para)Nodal Antibodies in Autoimmune Nodopathy and COVID-19 Vaccinated Individuals. [PDF]

J Peripher Nerv Syst
Appeltshauser L, Ruprecht C, Reusch J, Mees J, Glenewinkel H, Sommer C, Krone M, Wagenhäuser I, Doppler K, Petri N.   +9 more
europepmc   +1 more source

Matrix metalloproteinase‐9 regulates cell adhesion and membrane protrusive activity of ovarian cancer cells

FEBS Open Bio, EarlyView.
Matrix metalloproteinase‐9 (MMP9) drives ovarian cancer progression. Using MMP9‐null cells (M9‐KO) created from ovarian cancer cells, we found MMP9 loss did not block Epidermal Growth Factor (EGF)‐driven E‐cadherin dissolution or EMT but delayed and reduced EGF‐driven membrane protrusions. Transient MMP9 re‐expression drove membrane protrusion.
Claire Strauel, Sam Bennett, Natalie Ehlinger, Nelson Cook, Katelyn Marvin, Caleb L. Lines, Sam Reyes, Brooke Kirby, Shawn M. Ellerbroek   +8 more
wiley   +1 more source

Investigating antibody cross-reactivity and transmission dynamics of alphaviruses and flaviviruses using a multiplex serological assay. [PDF]

Nat Commun
Yman V, Rosado J, Ochida N, Garcia L, Gasasira MF, Baudemont G, Cramer E, Dupont-Rouzeyrol M, Huet K, Douine M, Sanna A, Lambert Y, Carrasco-Escobar G, Nolasco O, Gamboa D, Fall G, Ndiaye O, Faye O, Loucoubar C, Toure-Balde A, Niang M, Vigan-Womas I, Cauchemez S, White MT.   +23 more
europepmc   +1 more source